MEDICLIN Aktiengesellschaft (ETR:MED)
Germany · Delayed Price · Currency is EUR 4.360
+0.260 (6.34%)
Aug 4, 2026, 5:35 PM CET
ETR:MED Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 787.05 | 804.32 | - | 766.75 | 722.32 | 687.08 | |
Revenue Growth | 33.30% | - | - | 6.15% | 5.13% | 2.40% |
Cost of Revenue | - | - | - | 597.98 | 569.11 | 545.54 |
Gross Profit | 787.05 | 804.32 | - | 168.76 | 153.22 | 141.54 |
Selling, General & Admin | - | 75.37 | - | 70.03 | 62.3 | 56.32 |
Depreciation & Amortization Expenses | 13.96 | 60.22 | - | 86.01 | 71.4 | 73.66 |
Total Operating Expenses | 13.96 | 135.59 | 0 | 156.04 | 133.7 | 129.98 |
Operating Income | 33.68 | 55.36 | - | 12.72 | 90.92 | 11.56 |
Interest Income | 1.66 | 1.9 | 0 | 2.54 | 0.88 | 0.21 |
Interest Expense | -20.67 | -22.06 | - | -23.95 | -10.62 | -9.33 |
Total Non-Operating Income (Expense) | -19.02 | -20.16 | 0 | -21.41 | -9.74 | -9.12 |
Pretax Income | 40.66 | 35.2 | 0 | -8.69 | 9.78 | 2.45 |
Provision for Income Taxes | 11.28 | 9.3 | - | 2.04 | 0.06 | 0.96 |
Net Income | 29.38 | 25.9 | 0 | -10.72 | 9.72 | 1.49 |
Minority Interest in Earnings | 0.27 | 0.42 | - | 0.05 | 0.28 | 0.02 |
Net Income to Common | 29.11 | 25.49 | 0 | -10.78 | 9.44 | 1.46 |
Net Income Growth | 21.23% | - | - | - | 545.98% | - |
Shares Outstanding (Basic) | 48 | 48 | 48 | 48 | 48 | 48 |
Shares Outstanding (Diluted) | 48 | 48 | 48 | 48 | 48 | 48 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.61 | 0.54 | 0.52 | -0.23 | 0.20 | 0.03 |
EPS (Diluted) | 0.61 | 0.54 | 0.52 | -0.23 | 0.20 | 0.03 |
EPS Growth | -13.68% | 3.85% | - | - | 566.67% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 55.96 | 54.01 | 42.52 | 43.58 | 10.27 | 66.74 |
Free Cash Flow Growth | 11.21% | 27.02% | -2.43% | 324.41% | -84.61% | -30.80% |
Free Cash Flow Per Share | 1.18 | 1.14 | 0.90 | 0.92 | 0.22 | 1.40 |
Dividends Per Share | 0.040 | 0.040 | 0.040 | - | - | - |
Dividend Growth | 0% | 0% | - | - | - | - |
Gross Margin | 100.00% | 100.00% | - | 22.01% | 21.21% | 20.60% |
Operating Margin | 4.28% | 6.88% | - | 1.66% | 12.59% | 1.68% |
Profit Margin | 3.73% | 3.22% | - | -1.40% | 1.35% | 0.22% |
FCF Margin | 7.11% | 6.72% | - | 5.68% | 1.42% | 9.71% |
EBITDA | 94.89 | 115.58 | 50.28 | 98.73 | 162.33 | 85.22 |
EBITDA Margin | 12.06% | 14.37% | - | 12.88% | 22.47% | 12.40% |
EBIT | 33.68 | 55.36 | - | 12.72 | 90.92 | 11.56 |
EBIT Margin | 4.28% | 6.88% | - | 1.66% | 12.59% | 1.68% |
Effective Tax Rate | 27.74% | 26.41% | - | -23.42% | 0.59% | 39.28% |